Email Updates

Search form

You are here

Outbreak-focused vaccine coalition earmarks $54.9M for HIV group's Lassa fever effort

Include in
Media Coverage

Handing out tens of millions of dollars to an HIV-focused organization to develop a Lassa fever vaccine may sound like a far-fetched idea. But that’s just what the Coalition for Epidemic Preparedness Innovations (CEPI) has decided to do—for a valid scientific reason.

May 22, 2018
FiercePharma